Figure 1.
Pilot analysis of cardiac DNA methylation. A: multidimensional scaling (MDS) of top 10,000 cytosine-p-guanine (CpG) probes within the Illumina Human Methylation 450K array performed on cardiac left ventricle samples from patients with end-stage heart failure. The two principal components that account for the largest variance in DNA methylation were used to generate a scatterplot, flanked by density plots of each principal component. B: patient characteristics of cardiac samples used in the analysis. ACE-Inh, angiotensin-converting enzyme inhibitor; HF, heart failure; HTN, hypertension; LVEF left ventricular ejection fraction.